vaccines

FDA approves Pfizer’s RSV vaccine for older adults
FDA approves Pfizer’s RSV vaccine for older adults
Stat
Pfizer
vaccines
FDA
elderly
RSV
Abrysvo
Flag link:
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Biopharma Reporter
vaccines
MRNA
Merck
Asia-Pacific
Flag link:
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit
Fierce Pharma
Alnylam Pharmaceuticals
legal
patents
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Flag link:
EMA Panel Endorses Novavax's (NVAX) COVID vaccine for Full Approval
EMA Panel Endorses Novavax's (NVAX) COVID vaccine for Full Approval
Yahoo/Zacks.com
Novavax
EMA
Europe
vaccines
CHMP
COVID-19
Flag link:
Science finally figured out how to make effective RSV vaccines. Will seniors care?
Science finally figured out how to make effective RSV vaccines. Will seniors care?
Stat
RSV
vaccines
elderly
Pfizer
GSK
Flag link:
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
BioSpace
Merck
vaccines
Gardasil
legal
HPV
side effects
Flag link:
CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South
CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South
Medical Marketing and Media
CureVac
COVID-19
vaccines
Pfizer
BioNTech
patents legal
Flag link:
The CDC is worried about a mpox rebound and urges people to get vaccinated
The CDC is worried about a mpox rebound and urges people to get vaccinated
NPR
CDC
mpox
vaccines
Jynneos
Bavarian Nordic
Flag link:
FDA advisory panel backs Pfizer’s RSV vaccine, but expresses some safety concerns
FDA advisory panel backs Pfizer’s RSV vaccine, but expresses some safety concerns
Stat
Pfizer
RSV
vaccines
FDA
Flag link:
FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel
FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel
BioSpace
Pfizer
FDA
RSV
vaccines
Abrysvo
Flag link:
Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins
Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins
Drugs.com
universal flu vaccine
clinical trials
NIAID
MRNA
vaccines
Flag link:
Moderna hits back at Alnylam's 'baseless' patent infringement claims
Moderna hits back at Alnylam's 'baseless' patent infringement claims
Fierce Pharma
Moderna Therapeutics
Alnylam
MRNA
vaccines
legals
Flag link:
Pfizer RSV vaccine seen as effective against severe disease, FDA documents say
Pfizer RSV vaccine seen as effective against severe disease, FDA documents say
Stat
Pfizer
RSV
vaccines
infants
pregnancy
FDA
Flag link:
Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too
Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too
Motley Fool
Novavax
Pharma CEOs
John C. Jacobs
vaccines
layoffs
COVID-19/flu vaccines
Flag link:
GSK tees up Pfizer fight with pivotal meningitis vaccine data
GSK tees up Pfizer fight with pivotal meningitis vaccine data
Fierce Biotech
GSK
Pfizer
vaccines
meningitis
Flag link:
Novavax employs AI-based dose selection for Covid-influenza vaccine trials
Novavax employs AI-based dose selection for Covid-influenza vaccine trials
Clinical Trials Arena
Novavax
clinical trials
artificial intelligence
vaccines
COVID-19
COVID-flu vaccines
Flag link:
Codagenix initiates new study of live-attenuated vaccine in RSV
Codagenix initiates new study of live-attenuated vaccine in RSV
Clinical Trials Arena
Codagenix
RSV
vaccines
clinical trials
Flag link:
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
Yahoo/Reuters
BioNTech
Roche
Genentech
pancreatic cancer
MRNA
Nature
vaccines
Flag link:
Novavax cuts headcount by 25%, hitting hundreds of jobs, to align costs with dwindling COVID-19 market
Novavax cuts headcount by 25%, hitting hundreds of jobs, to align costs with dwindling COVID-19 market
Fierce Biotech
Novavax
layoffs
vaccines
COVID-19
Flag link:
Vir Biotechnology awarded $10 million grant by Bill & Melinda Gates Foundation to develop HIV vaccine
Vir Biotechnology awarded $10 million grant by Bill & Melinda Gates Foundation to develop HIV vaccine
Biopharma Reporter
Vir Biotechnology
Gates Foundation
vaccines
HIV
Flag link:

Pages